CP and ovarian neoplasm: In our study, the ovarian CSCs exhibited resistance to PTX and CP, whereas AZD4547 effectively reduced the stemness properties and survival rate of ovarian CSCs, suggesting that using AZD4547 to target FGF/FGFR signaling is a promising strategy for the elimination of CSCs in ovarian tumors.